XML 20 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes in Shareholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Additional Paid-In Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Restricted Stock
Restricted Stock
Treasury Stock
Performance Shares
Performance Shares
Treasury Stock
Beginning balance at Dec. 31, 2018 $ 262,830 $ 97,602 $ 171,780 $ (2,556) $ (3,996)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 19,240   19,240            
Other comprehensive income (loss) 10,094       10,094        
Restricted stock award grants 0 (1,055)   1,055          
Stock-based compensation expense 867 867              
Purchase of treasury stock           $ (994) $ (994) $ (240) $ (240)
Cash dividends declared (5,182)   (5,182)            
Ending balance at Jun. 30, 2019 $ 286,615 97,414 185,838 (2,735) 6,098        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Restricted stock award grants (in shares) 39,790                
Purchase of treasury stock (in shares) 40,000             9,088  
Cash dividends declared (in dollars per share) $ 0.34                
Beginning balance at Mar. 31, 2019 $ 274,959 97,139 178,662 (1,702) 860        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 9,767   9,767            
Other comprehensive income (loss) 5,238       5,238        
Stock-based compensation expense 275 275              
Purchase of treasury stock           $ (994) (994) $ (39) (39)
Cash dividends declared (2,591)   (2,591)            
Ending balance at Jun. 30, 2019 $ 286,615 97,414 185,838 (2,735) 6,098        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Purchase of treasury stock (in shares) 40,000         1,388      
Cash dividends declared (in dollars per share) $ 0.17                
Beginning balance at Dec. 31, 2019 $ 304,966 99,335 201,503 (2,811) 6,939        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 17,059   17,059            
Other comprehensive income (loss) 9,659       9,659        
Restricted stock award grants 0 (892)   892          
Performance based restricted stock award grants 0 (217)   217          
Stock-based compensation expense 835 835              
Issuance of common stock, net of issuance costs 3,313 3,313              
Purchase of treasury stock           $ (212) (212) $ (113) $ (113)
Cash dividends declared (5,235)   (5,235)            
Ending balance at Jun. 30, 2020 $ 330,272 102,374 213,327 (2,027) 16,598        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock, net of issuance costs (in shares) 115,790                
Restricted stock award grants (in shares) 35,160                
Performance-based restricted stock award (in shares) 8,351                
Purchase of treasury stock (in shares)           7,267   3,458  
Cash dividends declared (in dollars per share) $ 0.34                
Beginning balance at Mar. 31, 2020 $ 324,802 102,128 207,698 (2,026) 17,002        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 8,246   8,246            
Other comprehensive income (loss) (404)       (404)        
Stock-based compensation expense 286 286              
Issuance of common stock, net of issuance costs (40) (40)              
Purchase of treasury stock           $ (1) $ (1)    
Cash dividends declared (2,617)   (2,617)            
Ending balance at Jun. 30, 2020 $ 330,272 $ 102,374 $ 213,327 $ (2,027) $ 16,598        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock, net of issuance costs (in shares) 0                
Purchase of treasury stock (in shares)           56      
Cash dividends declared (in dollars per share) $ 0.17